Concepedia

Jan Stetka

JS

Statistics

Publications

8

Citations

202

H-Index

8

Active since

2014

Affiliations

University Hospital of Basel(Current)

University of Basel

SIB Swiss Institute of Bioinformatics

Palacký University Olomouc

Inserm

Jan Stetka is an author at University Hospital of Basel specializing in jak2 mutations, molecular oncology, and myeloproliferative neoplasms.

ORCID

Publications per year

2014–2024

8

Publications

8

<i>JAK2</i>-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality

Tata Nageswara Rao, Nils Hansen, Jan Stetka et al. · Blood · 2021 · 72 citations · Full text

, , +13

Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation

Jan Stetka, Pavla Vyhlidalova, Lucie Lanikova et al. · Oncogene · 2019 · 39 citations · Full text

, , +16

The glutaminase inhibitor CB-839 targets metabolic dependencies of <i>JAK2</i>-mutant hematopoiesis in MPN

Marc Usart, Nils Hansen, Jan Stetka et al. · Blood Advances · 2024 · 21 citations · Full text

, , +14

Loss of <i>Dnmt3a</i> increases self-renewal and resistance to pegIFN-α in <i>JAK2</i>-V617F–positive myeloproliferative neoplasms

Marc Usart, Jan Stetka, Damien Luque Paz et al. · Blood · 2024 · 18 citations · Full text

, , +17

Effect of 9-cis retinoic acid and all-trans retinoic acid in combination with verapamil on P-glycoprotein expression in L1210 cells

Albert Breier, Jan Stetka, V. Boháčová et al. · Neoplasma · 2014 · 15 citations · Full text

, , +13

1–5 of 8